SCHEMBL1963105

SCHEMBL1963105

O=C(Nc1ccccn1)ON1C(=O)CCC1=O

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.51
RAB9A P51151 4/20 0.51
PKM P14618 2/20 0.51
GAA P10253 1/20 0.49
KDM4E B2RXH2 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
ADORA3 P0DMS8 1/20 0.45
PIM1 P11309 1/20 0.45
ADORA2A P29274 1/20 0.45
ADORA2B P29275 1/20 0.45
ADORA1 P30542 1/20 0.45
FLT3 P36888 1/20 0.45
PIM3 Q86V86 1/20 0.45
AURKB Q96GD4 1/20 0.45
LMNA P02545 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
F2 P00734 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL992708 0.77 KMT2A (0.56) NPC1RAB9APKMGAAKDM4E
SCHEMBL28131008 0.77 NPC1 (0.56) NPC1RAB9APKMGAAKDM4E
SCHEMBL1205198 0.76 SMN1; SMN2 (0.51) NPC1RAB9AGAAKDM4ESMN1; SMN2
SCHEMBL16261005 0.76 NPC1 (0.50) NPC1RAB9ASMN1; SMN2KMT2AADORA3
SCHEMBL17266541 0.74 NPC1 (0.66) NPC1RAB9APKMGAAKDM4E
SCHEMBL29655221 0.74 NPC1 (0.66) NPC1RAB9APKMGAAKDM4E
SCHEMBL11709551 0.73 MAPT (0.53) NPC1RAB9AGAAKDM4ESMN1; SMN2
SCHEMBL9089971 0.73 RAB9A (0.63) NPC1RAB9APKMGAAKDM4E
SCHEMBL1962172 0.72 NPC1 (0.49) NPC1RAB9APKMKDM4EMEN1
SCHEMBL850424 0.72 NPC1 (0.59) NPC1RAB9AKDM4ESMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112041319-B Triazole, imidazole and pyrrole fused piperazine derivatives and their use as mGlu5Use of modulators of receptors 利康化学与制药工业有限公司 2024-05-14 CN disclosed
US-11591337-B2 Substituted [1,2,4]triazolo[4,3-a]pyrazines as modulators of mGlu5 receptors RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A. (IT) 2023-02-28 US disclosed
US-20210047331-A1 TRIAZOLE, IMIDAZOLE AND PYRROLE CONDENSED PIPERAZINE DERIVATIVES AND THEIR USE AS MODULATORS OF mGlu5 RECEPTORS RECORDATI IND CHIMICA E FARMACEUTICA S P A (IT) 2021-02-18 US disclosed
EP-3743429-A1 TRIAZOLE, IMIDAZOLE AND PYRROLE CONDENSED PIPERAZINE DERIVATIVES AND THEIR USE AS MODULATORS OF mGlu5 RECEPTORS RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.a. (IT) 2020-12-02 EP disclosed
WO-2019145214-A1 TRIAZOLE, IMIDAZOLE AND PYRROLE CONDENSED PIPERAZINE DERIVATIVES AND THEIR USE AS MODULATORS OF mGlu5 RECEPTORS RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A (IT) 2019-08-01 WO disclosed
EP-1919892-B1 ISOINDOLE-IMIDE COMPOUNDS AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME CELGENE CORP (US) 2013-08-14 EP disclosed
US-8481568-B2 Isoindole-imide compounds and compositions comprising and methods of using the same CELGENE CORPORATION (US) 2013-07-09 US disclosed
US-20110144158-A1 ISOINDOLE-IMIDE COMPOUNDS AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME SEPRACOR INC. 2011-06-16 US disclosed
EP-1919892-A2 ISOINDOLE-IMIDE COMPOUNDS AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME CELGENE CORPORATION (US) 2008-05-14 EP disclosed
WO-2007027527-A2 ISOINDOLE-IMIDE COMPOUNDS AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME CELGENE CORPORATION (US) 2007-03-08 WO disclosed
US-20070049618-A1 Isoindole-imide compounds and compositions comprising and methods of using the same CELGENE CORPORATION 2007-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210047331-A1 TRIAZOLE, IMIDAZOLE AND PYRROLE CONDENSED PIPERAZINE DERIVATIVES AND THEIR USE AS MODULATORS OF mGlu5 RECEPTORS GRM5, GRIK5, GRIN3A NPC1 2300/4885RAB9A 1808/4885PKM 1236/4885
US-20110144158-A1 ISOINDOLE-IMIDE COMPOUNDS AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME SI, CYP3A5, CYP2D6 NPC1 1007/4885RAB9A 914/4885PKM 1567/4885
US-20070049618-A1 Isoindole-imide compounds and compositions comprising and methods of using the same SI, CYP3A5, CYP2D6 NPC1 1007/4885RAB9A 914/4885PKM 1567/4885
US-11591337-B2 Substituted [1,2,4]triazolo[4,3-a]pyrazines as modulators of mGlu5 receptors GRM5, GRIK5, GRM1 NPC1 2081/4885RAB9A 1986/4885PKM 1270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.